8-K
Current Report
ALX ONCOLOGY HOLDINGS INC Filed Acc 0000950170-25-033504
Exit or restructuring costs · Executive or director change
- Item 2.05 Costs associated with exit or disposal activities
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading alxo-20250228.htm…